Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-exon4, gB, pp150, and pp28 in healthy individuals: Reevaluation of prevalence of IE1-specific CTLs

Citation
Z. Gyulai et al., Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-exon4, gB, pp150, and pp28 in healthy individuals: Reevaluation of prevalence of IE1-specific CTLs, J INFEC DIS, 181(5), 2000, pp. 1537-1546
Citations number
40
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF INFECTIOUS DISEASES
ISSN journal
00221899 → ACNP
Volume
181
Issue
5
Year of publication
2000
Pages
1537 - 1546
Database
ISI
SICI code
0022-1899(200005)181:5<1537:CTL(RT>2.0.ZU;2-1
Abstract
The prevalence of human cytomegalovirus (HCMV) pp65-, pp150-, IE1-exon4-, g B- and pp28-specific cytotoxic T lymphocyte (CTL) responses was compared am ong 34 healthy individuals, grouped by neutralizing antibody titers, Modera tely and highly seropositive donors showed predominantly pp65- and IE1-exon 4-specific CTL responses (92% and 76% of the donors, respectively), with si milar precursor frequencies in the 2 donors tested. In addition, highly ser opositive and a few moderately seropositive donors showed CTL responses to gB and pp150 (33% and 30% of the donors, respectively). No individual recog nized pp28 as a target in the CTL assay. Phenotypic analysis revealed a mix ed effector population of CD4(+) and CD8(+) (1 donor) or only CD8(+) cells for pp65-specific effectors (2 donors). IE1-exon4- and pp150-specific effec ters were CD8(+) (2 donors and 1 donor, respectively), whereas gB-specific CTLs were CD4(+) (1 donor). These data may help to design a cellular immuni ty-based vaccine effective against HCMV disease.